Table 2 Manifestations of 18 patients. Age and time from onset of vitreous opacity to onset of different manifestations shown as median (min-max)
Manifestation | Prevalence | Age (years) | Onset (years) | Intervention/Observation | Patients/eyes |
|---|---|---|---|---|---|
Vitreous opacity | 100.0% | 46 (37–61) | 0 | Observation | 2/5 |
Pars plana vitrectomy | 16/31 | ||||
Retinal amyloid angiopathy | 88.9% | 55 (40–65) | 3 (1–15) | Observation | 16/32 |
Recurrence of vitreous opacity | 50.0% | 53 (49–64) | 10 (4–18) | Observation | 4/7 |
Pars plana vitrectomy | 5/7 | ||||
Neovascular glaucoma | 33.3% | 55 (49–65) | 12 (9–15) | anti-glaucoma medication | 1/2 |
Trabeculectomy | 1/2 | ||||
Glaucoma valve implantation | 2/3 | ||||
Retinal photocoagulation | 3/4 | ||||
Intravitreal injection of Anti-VEGF | 2/3 | ||||
Retinal detachment | 11.1% | 54 | 10/18 | Observation | 2/2 |
Intraoperative outbreak of choroidal hemorrhage | 5.6% | 56 | 10 | Hematoma clearance | 1/1 |